Introduction
released from the bleeding cause secondary, delayed damage leading to neuronal cell death. 15 
110
Therapeutic strategies being different from those employed for ischemic stroke are needed to 111 promote tissue repair after hemorrhagic stroke.
112
Most preclinical ICH studies use one of two large hemorrhage rodent models: other hand, using models with spontaneously developing hemorrhages is challenging due to 118 the difficulty to detect their occurrence and variable lesion sizes and locations. In a large 119 study in stroke-prone spontaneously hypertensive rats, 7.4% showed bleeding and 17.9% 120 hemorrhagic transformation in various locations. 16 
121
Some genetic models have been developed to mimic cerebral microbleeds.
17,18

122
Cerebral microbleeds cause small lesions that, theoretically, may foster tissue repair 123 approaches. However, they are often clinically silent 19 and are hard to access, particularly 124 when situated in subcortical regions. Therefore, they are currently no target for therapeutic BDNF=brain-derived neurotrophic factor; CIMT=constraint-induced movement therapy; DG=dentate gyrus; EE=enriched environment; ET- 
